205 related articles for article (PubMed ID: 20976449)
1. Analysis of circulating regulatory T cells in patients with metastatic prostate cancer pre- versus post-vaccination.
Vergati M; Cereda V; Madan RA; Gulley JL; Huen NY; Rogers CJ; Hance KW; Arlen PM; Schlom J; Tsang KY
Cancer Immunol Immunother; 2011 Feb; 60(2):197-206. PubMed ID: 20976449
[TBL] [Abstract][Full Text] [Related]
2. Immunologic and prognostic factors associated with overall survival employing a poxviral-based PSA vaccine in metastatic castrate-resistant prostate cancer.
Gulley JL; Arlen PM; Madan RA; Tsang KY; Pazdur MP; Skarupa L; Jones JL; Poole DJ; Higgins JP; Hodge JW; Cereda V; Vergati M; Steinberg SM; Halabi S; Jones E; Chen C; Parnes H; Wright JJ; Dahut WL; Schlom J
Cancer Immunol Immunother; 2010 May; 59(5):663-74. PubMed ID: 19890632
[TBL] [Abstract][Full Text] [Related]
3. Analysis of circulating regulatory T cells (CD4+CD25+CD127-) after cryosurgery in prostate cancer.
Si TG; Wang JP; Guo Z
Asian J Androl; 2013 Jul; 15(4):461-5. PubMed ID: 23728588
[TBL] [Abstract][Full Text] [Related]
4. Identification by digital immunohistochemistry of intratumoral changes of immune infiltrates after vaccine in the absence of modifications of PBMC immune cell subsets.
Farsaci B; Jochems C; Grenga I; Donahue RN; Tucker JA; Pinto PA; Merino MJ; Heery CR; Madan RA; Gulley JL; Schlom J
Int J Cancer; 2014 Aug; 135(4):862-70. PubMed ID: 24474335
[TBL] [Abstract][Full Text] [Related]
5. Up-regulation of proliferative and migratory genes in regulatory T cells from patients with metastatic castration-resistant prostate cancer.
Huen NY; Pang AL; Tucker JA; Lee TL; Vergati M; Jochems C; Intrivici C; Cereda V; Chan WY; Rennert OM; Madan RA; Gulley JL; Schlom J; Tsang KY
Int J Cancer; 2013 Jul; 133(2):373-82. PubMed ID: 23319273
[TBL] [Abstract][Full Text] [Related]
6. A combination trial of vaccine plus ipilimumab in metastatic castration-resistant prostate cancer patients: immune correlates.
Jochems C; Tucker JA; Tsang KY; Madan RA; Dahut WL; Liewehr DJ; Steinberg SM; Gulley JL; Schlom J
Cancer Immunol Immunother; 2014 Apr; 63(4):407-18. PubMed ID: 24514956
[TBL] [Abstract][Full Text] [Related]
7. Increased CD8+ T-cell function following castration and immunization is countered by parallel expansion of regulatory T cells.
Tang S; Moore ML; Grayson JM; Dubey P
Cancer Res; 2012 Apr; 72(8):1975-85. PubMed ID: 22374980
[TBL] [Abstract][Full Text] [Related]
8. Immunoregulatory T cells in the peripheral blood of melanoma patients treated with melanoma antigen-pulsed mature monocyte-derived dendritic cell vaccination.
Nakai N; Katoh N; Kitagawa T; Ueda E; Takenaka H; Kishimoto S
J Dermatol Sci; 2009 Apr; 54(1):31-7. PubMed ID: 19157789
[TBL] [Abstract][Full Text] [Related]
9. Pretreatment frequency of circulating IL-17+ CD4+ T-cells, but not Tregs, correlates with clinical response to whole-cell vaccination in prostate cancer patients.
Derhovanessian E; Adams V; Hähnel K; Groeger A; Pandha H; Ward S; Pawelec G
Int J Cancer; 2009 Sep; 125(6):1372-9. PubMed ID: 19533748
[TBL] [Abstract][Full Text] [Related]
10. A GMCSF-Neuroantigen Tolerogenic Vaccine Elicits Systemic Lymphocytosis of CD4
Moorman CD; Curtis AD; Bastian AG; Elliott SE; Mannie MD
Front Immunol; 2018; 9():3119. PubMed ID: 30687323
[TBL] [Abstract][Full Text] [Related]
11. Forced LIGHT expression in prostate tumors overcomes Treg mediated immunosuppression and synergizes with a prostate tumor therapeutic vaccine by recruiting effector T lymphocytes.
Yan L; Da Silva DM; Verma B; Gray A; Brand HE; Skeate JG; Porras TB; Kanodia S; Kast WM
Prostate; 2015 Feb; 75(3):280-91. PubMed ID: 25399517
[TBL] [Abstract][Full Text] [Related]
12. Clinical Implications of CD4
Wada M; Tsuchikawa T; Kyogoku N; Abiko T; Miyauchi K; Takeuchi S; Kuwatani T; Shichinohe T; Miyahara Y; Kageyama S; Ikeda H; Shiku H; Hirano S
Anticancer Res; 2018 Mar; 38(3):1435-1444. PubMed ID: 29491069
[TBL] [Abstract][Full Text] [Related]
13. [The phenotype and function of CD4+ CD25+ regulatory T cells in hepatitis B patients].
Fu JL; Xu DP; Shi M; Zhang H; Jin L; Tang ZR; Wang FS
Zhonghua Nei Ke Za Zhi; 2006 Aug; 45(8):642-5. PubMed ID: 17074148
[TBL] [Abstract][Full Text] [Related]
14. Levels of circulating regulatory CD4+CD25+ T cells are decreased in breast cancer patients after vaccination with a HER2/neu peptide (E75) and GM-CSF vaccine.
Hueman MT; Stojadinovic A; Storrer CE; Foley RJ; Gurney JM; Shriver CD; Ponniah S; Peoples GE
Breast Cancer Res Treat; 2006 Jul; 98(1):17-29. PubMed ID: 16758122
[TBL] [Abstract][Full Text] [Related]
15. Enhanced functionality of CD4+CD25(high)FoxP3+ regulatory T cells in the peripheral blood of patients with prostate cancer.
Yokokawa J; Cereda V; Remondo C; Gulley JL; Arlen PM; Schlom J; Tsang KY
Clin Cancer Res; 2008 Feb; 14(4):1032-40. PubMed ID: 18281535
[TBL] [Abstract][Full Text] [Related]
16. Ipilimumab and a poxviral vaccine targeting prostate-specific antigen in metastatic castration-resistant prostate cancer: a phase 1 dose-escalation trial.
Madan RA; Mohebtash M; Arlen PM; Vergati M; Rauckhorst M; Steinberg SM; Tsang KY; Poole DJ; Parnes HL; Wright JJ; Dahut WL; Schlom J; Gulley JL
Lancet Oncol; 2012 May; 13(5):501-8. PubMed ID: 22326924
[TBL] [Abstract][Full Text] [Related]
17. Reduced frequency and functional defects of CD4
Luo L; Zeng X; Huang Z; Luo S; Qin L; Li S
Reprod Biol Endocrinol; 2020 Jun; 18(1):62. PubMed ID: 32522204
[TBL] [Abstract][Full Text] [Related]
18. Monitoring of regulatory T cell frequencies and expression of CTLA-4 on T cells, before and after DC vaccination, can predict survival in GBM patients.
Fong B; Jin R; Wang X; Safaee M; Lisiero DN; Yang I; Li G; Liau LM; Prins RM
PLoS One; 2012; 7(4):e32614. PubMed ID: 22485134
[TBL] [Abstract][Full Text] [Related]
19. Current vaccination strategies for prostate cancer.
Joniau S; Abrahamsson PA; Bellmunt J; Figdor C; Hamdy F; Verhagen P; Vogelzang NJ; Wirth M; Van Poppel H; Osanto S
Eur Urol; 2012 Feb; 61(2):290-306. PubMed ID: 22001436
[TBL] [Abstract][Full Text] [Related]
20. CTLA-4 blockade following relapse of malignancy after allogeneic stem cell transplantation is associated with T cell activation but not with increased levels of T regulatory cells.
Zhou J; Bashey A; Zhong R; Corringham S; Messer K; Pu M; Ma W; Chut T; Soiffer R; Mitrovich RC; Lowy I; Ball ED
Biol Blood Marrow Transplant; 2011 May; 17(5):682-92. PubMed ID: 20713164
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
